当前位置: X-MOL 学术J. Radioanal. Nucl. Chem. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Regular production and supply of ready-to-use gallium-68 radiopharmaceuticals: centralized radiopharmacy concept with supply experience of 300 doses
Journal of Radioanalytical and Nuclear Chemistry ( IF 1.5 ) Pub Date : 2021-08-15 , DOI: 10.1007/s10967-021-07921-7
Dheeraj Kumar 1 , Anupam Mathur 1 , Vrinda Prashant 1 , Shubhangi Mirapurkar 1 , Soumen Das 1 , Sanjeev Kumar 1 , V. V. Murhekar 1
Affiliation  

The present work illustrates the feasibility of production and supply of ready-to-use gallium-68 (68Ga) radiopharmaceuticals, similar to [18F]FDG, through a centralized production facility. The supply logistic from centralized facility to various imaging centers situated within the radius of 50 km was investigated using germanium-68/gallium-68 generator system of fixed (1.85 GBq) capacity. However, the logistics discussed and conclusion drawn can be definitely extrapolated to many other 68Ga radiopharmaceuticals, where the 68Ga radioisotope used is produced via direct cyclotron route.



中文翻译:

定期生产和供应即用型镓 68 放射性药物:具有 300 剂供应经验的集中放射性药物概念

目前的工作说明了通过集中生产设施生产和供应类似于 [ 18 F] FDG 的即用型镓 68 ( 68 Ga) 放射性药物的可行性。使用固定容量 (1.85 GBq) 的锗 68/镓 68 发生器系统研究了从集中设施到位于 50 公里半径内的各个成像中心的供应物流。然而,所讨论的物流和得出的结论肯定可以外推到许多其他68 Ga 放射性药物,其中使用的68 Ga 放射性同位素是通过直接回旋加速路线生产的。

更新日期:2021-08-19
down
wechat
bug